You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. DEVELOPMENT OF A BIOLOGICALLY-ACTIVE VASCULAR GRAFT

    SBC: BIOMOD SURFACES            Topic: N/A

    Medium (6-8mm) and small (

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  2. DEVELOPMENT OF A BIOLOGICALLY-ACTIVE VASCULAR GRAFT

    SBC: BIOMOD SURFACES            Topic: N/A

    Medium (6-8mm) and small (

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  3. NANOFIBER TECHNOLOGY IN SMALL-DIAMETER VASCULAR GRAFTS

    SBC: BIOMOD SURFACES            Topic: N/A

    There is no small-diameter vascular prosthesis that is capable of emulating the biologic and physical properties of the normal arterial wall. The goal of this proposal is to develop a small-diameter prosthetic vascular graft using nanofiber technology. Our hypothesis is creating a nanofibrous vascular graft by electrospinning an ionic polyurethane will result in a graft that possesses properties s ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. DETECTION OF PRION PROTEIN IN BLOOD

    SBC: SERACARE LIFE SCIENCES, INC.            Topic: N/A

    Prion diseases are 100 percent fatal, there is no treatment available, and cannot be diagnosed prior to the occurrence of symptoms. There is a public health need and an enormous market for a screening test that can help protect the blood supply, screen live animals, and ensure food safety. We propose to develop and validate an innovative, highly sensitive screening method for the detection of the ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. IPformatics: An Integrated Knowledgebase of Patent Claims and Genomic Data

    SBC: BIOSPHEREX, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This is a proposal to create a knowledgebase of the intellectual property rights that exist in human genes. When completed, the knowledgebase will have three distinct elements: (1) a searchable sequence component that contains nucleotide and amino sequences listed in U.S. Patents; (2) a gene patent component that links each human gene with the U.S. patents whic ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  6. Neuroprotective Drugs for Spinal Cord Injury

    SBC: Biostream Therapeutics, Inc.            Topic: N/A

    DESCRIPTION: (Adapted from the Applicant's Abstract) Traumatic spinal cord injury (SCI) leads to permanent loss of motor function and control of function below the level of the injury. A significant portion of the loss is due to secondary factors rather than the initial trauma. These factors include increased extracellular concentrations of glutamate which ha ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  7. Neuroadaptive effects after chronic CTDP 31446 treatment

    SBC: Biostream Therapeutics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Cocaine abuse remains a grave concern for the American, and increasingly the world, population. As no current therapeutic agents are available to assist cocaine addicts in achieving and maintaining abstinence it is important that new pharmacotherapies be developed. One important question not usually addressed in the development ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  8. Novel pharmacotherapies for treatment of ADHD

    SBC: Biostream Therapeutics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Attention-deficit hyperactivity disorder (ADHD) is a common neuropsychiatric condition characterized by hyperactivity, inattention and impulsivity, typically in school-aged boys. Psychostimulants, including methylphenidate and amphetamines, are commonly used to alleviate symptoms of ADHD. However, these medications are typically associated with undesirable sid ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  9. Thromboresistant vascular grafts:heparin-peptidomimetics

    SBC: BIOSURFACE ENGINEERING TECHNOLOGIES            Topic: N/A

    Thrombosis of synthetic vascular grafts is a major problem with current grafts that necessitates prophylaxis, can lead to loss of patency with an attendant need for repeat surgery, and comes with a high risk of limb loss. The applicant proposes to develop thromboresistant extended polytetrafluoroethylene (ePTFE) vascular grafts that use an absorbed coating of heparin to control acute and subacute ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Development of Infection-Resistant Suture Materials

    SBC: BIOSURFACES INC            Topic: N/A

    DESCRIPTION (provided by applicant): Infection remains as one of the major complications associated with utilizing biomaterials. Surgical site infections account for approximately 14-16% of the 2.4-million nosocomial infections in the United States, with these infections resulting in increased patient morbidity and mortality. The inherent bulk properties of various biomaterials, including those th ...

    STTR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government